Charles E. Sheedy is 10% Owner at Nuo Therapeutics, Inc. (AURX). They have made 8 open-market trades across 1 company since 2017, most recently 2025-07-30.
CIK 0001005483
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
8 open-market purchases totalling $2.8M since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AURX | 11,570,833 | — |
| PrivateUnlisted | 3,066,312 | — |
| Total | $0 |
Shares reported on the most recent Form 4, priced at the 2025-08-01 close. 2 holdings could not be priced and are excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AURX | BUY | 2025-07-30 | 2025-08-01 | $1.50 | $400K | N/A | N/A | N/A |
| AURX | BUY | 2024-09-18 | 2024-09-19 | $0.75 | $94K | N/A | N/A | N/A |
| AURX | BUY | 2024-05-20 | 2024-05-21 | $0.75 | $75K | N/A | N/A | N/A |
| AURX | BUY | 2023-12-19 | 2023-12-20 | $0.50 | $75K | N/A | N/A | N/A |
| AURX | BUY | 2023-08-01 | 2023-08-04 | $2.00 | $125K | N/A | N/A | N/A |
| AURX | BUY | 2022-04-29 | 2022-05-02 | $1.00 | $805K | N/A | N/A | N/A |
| AURX | BUY | 2020-10-05 | 2022-04-26 | $0.40 | $70K | N/A | N/A | N/A |
| AURX | BUY | 2017-08-10 | 2017-08-14 | $0.22 | $1.1M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.